Literature DB >> 32877523

Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma.

Hamza Hashmi1, Abu-Sayeef Mirza2, Alicia Darwin3, Constantine Logothetis2, Franco Garcia2, Anuhya Kommalapati4, Rahul S Mhaskar5, Christina Bachmeier1, Julio C Chavez4,6, Bijal Shah4,6, Javier Pinilla-Ibarz4,6, Farhad Khimani1,6, Aleksandr Lazaryan1,6, Hien Liu1,6, Marco L Davila1,6, Frederick L Locke1,6, Taiga Nishihori1,6, Michael D Jain1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32877523      PMCID： PMC7479945          DOI： 10.1182/bloodadvances.2020002060

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  16 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 2.  Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.

Authors:  Mohammad Faizan Zahid; M Hassan Murad; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Alok Khorana; Alex C Spyropoulos; Shahrukh K Hashmi
Journal:  Ann Hematol       Date:  2016-04-22       Impact factor: 3.673

Review 3.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

4.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

5.  Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.

Authors:  Livia Hegerova; Adam Bachan; Qing Cao; Huong X Vu; John Rogosheske; Mark T Reding; Claudio G Brunstein; Mukta Arora; Celalettin Ustun; Gregory M Vercellotti; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-25       Impact factor: 5.742

6.  Current concepts in the diagnosis and management of cytokine release syndrome.

Authors:  Daniel W Lee; Rebecca Gardner; David L Porter; Chrystal U Louis; Nabil Ahmed; Michael Jensen; Stephan A Grupp; Crystal L Mackall
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

7.  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Authors:  Nigel S Key; Alok A Khorana; Nicole M Kuderer; Kari Bohlke; Agnes Y Y Lee; Juan I Arcelus; Sandra L Wong; Edward P Balaban; Christopher R Flowers; Charles W Francis; Leigh E Gates; Ajay K Kakkar; Mark N Levine; Howard A Liebman; Margaret A Tempero; Gary H Lyman; Anna Falanga
Journal:  J Clin Oncol       Date:  2019-08-05       Impact factor: 44.544

Review 8.  Cytokine and chemokine regulation of venous thromboembolism.

Authors:  Maria Y Najem; Francis Couturaud; Catherine A Lemarié
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

9.  Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.

Authors:  Frederick L Locke; Sattva S Neelapu; Nancy L Bartlett; Tanya Siddiqi; Julio C Chavez; Chitra M Hosing; Armin Ghobadi; Lihua E Budde; Adrian Bot; John M Rossi; Yizhou Jiang; Allen X Xue; Meg Elias; Jeff Aycock; Jeff Wiezorek; William Y Go
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

10.  Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy.

Authors:  Haiyan Liu; Ye Yang; Jie Jiang; Xinfeng Wang; Chenlu Zhang; Yijing Jiang; Lemin Hong; Hongming Huang
Journal:  Onco Targets Ther       Date:  2019-10-30       Impact factor: 4.147
View more
  1 in total

1.  Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.

Authors:  Adam Goldman; Elad Maor; David Bomze; Jennifer E Liu; Joerg Herrmann; Joshua Fein; Richard M Steingart; Syed S Mahmood; Wendy L Schaffer; Miguel-Angel Perales; Roni Shouval
Journal:  J Am Coll Cardiol       Date:  2021-11-02       Impact factor: 24.094
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.